Holistic Considerations in Optimizing a Sterile Product Package to Ensure Container Closure Integrity

Reference

1. 1.↵
   United States Pharmacopeial Convention. <1207> Packaging Integrity Evaluation—Sterile Products.

   Google Scholar
2. 2.↵
   ASTM D2240 Standard Test Method for Rubber Property—Durometer Hardness.

   Google Scholar
3. 3.↵
   West Pharmaceutical Services Materials Development, Review of Historic Formulations, 2016.

   Google Scholar
4. 4.↵
   1. Ward I. M.,
   2. Sweeney J.

   An Introduction to the Mechanical Properties of Solid Polymers, 2nd ed.; John Wiley & Sons: Hoboken, NJ, 2004.

   Google Scholar
5. 5.↵
   1. Hiemenz P. C.,
   2. Lodge T. P.

   Polymer Chemistry, 2nd ed.; CRC Press: Boca Raton, FL, 2007.

   Google Scholar
6. 6.↵
   1. Zeng Q,
   2. Zhao C.

   Critical Consideration in Time-Dependent Evaluation and Modeling for Rubber Stopper Seal Performance. Presented at the PDA Europe Parenteral Packaging Meeting, Barcelona, Spain, 2017.

   Google Scholar
7. 7.↵
   United Seal & Rubber Co., Inc. Designing and Producing a High Performance Gasket or Seal. e-book, 2013.

   Google Scholar
8. 8.↵
   1. Chose T.

   Live Science, June 4, 2013, Live Science Publication, Tia Chose, Senior Writer.

   Google Scholar
9. 9.↵
   1. Dorison A.,
   2. Ludema K. C.

   Chapter 9. Lubricated Friction. In Mechanics and Chemistry In Lubrication, Dorison A., Ludema K. C., Eds.; Elsevier Science Publishers B. V.: Amsterdam, The Netherlands, 1985; Tribology Series Vol. 9, pp 178–197.

   Google Scholar
10. 10.↵
    1. Jones L. S.,
    2. Kaufmann A.,
    3. Middaugh C. R.

    Silicone Oil Induced Aggregation of Proteins. J. Pharm. Sci. 2005, 94 (4), 918–927.

    OpenUrlCrossRefPubMedGoogle Scholar
11. 11.↵
    1. Thirumangalathu R.,
    2. Krishnan S.,
    3. Ricci M. S.,
    4. Brems D. N.,
    5. Randolph T. W.,
    6. Carpenter J. F.

    Silicone Oil- and Agitation-Induced Aggregation of a Monoclonal Antibody in Aqueous Solution. J. Pharm. Sci. 2009, 98 (9), 3167–3181.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
12. 12.↵
    1. Rey L.,
    2. May J.

    1. DeGrazio F.

    Chapter 9. Closure and Container Considerations in Lyophilization. In Freeze-Drying Lyophilization of Pharmaceutical and Biological Products, 2nd ed.; Rey L., May J., Eds.; Informa Healthcare: New York, 2010; Vol. 137.

    Google Scholar
13. 13.↵
    1. Vincent J.

    Chapter 1. Structural Biomaterials. In Basic Elasticity and Viscoelasticity, 3rd ed.; Princeton University Press: Princeton, NJ, 2012.

    Google Scholar
14. 14.↵
    1. Morton D. K.,
    2. Lordi N. G.

    Quantitative and Mechanistic Measurements of Container/Closure Integrity: Viscoelastic Measurements of Elastomeric Closures. PDA J. Pharm. Sci. Technol. 1988, 42 (4), 57–61.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
15. 15.↵
    1. Davidson K.,
    2. Mangus J.

    Selecting and Verifying Integral Packaging Systems for Injectable Drug Products. Poster presented at the PDA Annual Meeting, Las Vegas, NV, 2015.

    Google Scholar
16. 16.↵
    PDA Technical Report No. 76. Identification and Classification of Visible Nonconformities in Elastomeric Components and Aluminum Seals for Parenteral Packaging; PDA: Bethesda, MD, 2016.

    Google Scholar
17. 17.↵
    1. Lam P.,
    2. Stern A.

    Visualization Techniques for Assessing Design Factors That Affect Interaction between Pharmaceutical Vials and Stoppers. PDA J. Pharm. Sci. Technol. 2010, 64 (2), 182–187.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
18. 18.↵
    1. Lysfjord J.

    1. Bogle F. W.,
    2. Asselta R. P.,
    3. Pepper L.

    Chapter 13. Crimp Sealing Parenteral Vials. In Practical Aseptic Processing: Fill Finish, Lysfjord J., Ed.; PDA and Davis Healthcare International Publishing: Bethesda, MD and River Grove, IL, respectively, 2009; Vol. 1, pp 261–273.

    OpenUrlGoogle Scholar
19. 19.↵
    1. Mathaes R.,
    2. Mahler H. C.,
    3. Buettiker J. P.,
    4. Roehl H.,
    5. Lam P.,
    6. Brown H.,
    7. Luemkemann J.,
    8. Adler M.,
    9. Huwyler J.,
    10. Streubel A.,
    11. Mohl S.

    The Pharmaceutical Vial Capping Process: Container Closure Systems, Capping Equipment, Regulatory Framework, and Seal Quality Tests. Eur. J. Pharm. Biopharm. 2016, 99, 54–64.

    OpenUrlPubMedGoogle Scholar
20. 20.↵
    1. Mathaes R.,
    2. Mahler H.,
    3. Roggo Y.,
    4. Ovadia R.,
    5. Lam P.,
    6. Stauch O.,
    7. Vogt M.,
    8. Roehl H.,
    9. Huwyler J.,
    10. Mohl S.,
    11. Streubel A.

    Impact of Vial Capping on Residual Seal Force and Container Closure Integrity. PDA J. Pharm. Sci. Technol. 2016, 70 (1), 12–29.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
21. 21.↵
    1. Asselta R.

    Parenteral Vial Sealing and Integrity Webinar. Genesis Packaging Technologies: Exton, PA; January 2017.

    Google Scholar
22. 22.↵
    United States Pharmacopeia. <1207.1> Package Integrity Testing in the Product Life Cycle—Test Method Selection and Validation. United States Pharmacopeial Convention: Rockville, MD, 2016.

    Google Scholar
23. 23.↵
    United States Pharmacopeia. <1207> Section 5. Product-Package Quality Requirements and the Maximum Allowable Leakage Limit. United States Pharmacopeial Convention: Rockville, MD, 2016.

    Google Scholar
24. 24.↵
    1. Paskiet D.,
    2. Asselta R.

    Qualifying Integral Container Closure Systems. Presented at the PDA Annual Meeting, San Antonio, TX, 2014.

    Google Scholar
25. 25.↵
    1. Morton D. K.,
    2. Lordi N. G.

    Residual Seal Force Measurements of Parenteral Vials. I. Methodology. PDA J. Pharm. Sci. Technol. 1988, 42 (1), 23–29.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
26. 26.↵
    1. Mathaes R.,
    2. Mahler H.,
    3. Roggo Y.,
    4. Huwyler J.,
    5. Eder J.,
    6. Fritsch K.,
    7. Posset T.,
    8. Mohl S.,
    9. Streubel A.

    Influence of Different Container Closure Systems and Capping Process Parameters on Product Quality and Container Closure Integrity in GMP Drug Product Manufacturing. PDA J. Pharm. Sci. Technol. 2016, 70 (2), 109–119.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
27. 27.↵
    FDA Guidance for Industry. Drug Stability Guidelines. Section C3. Temperature. December 9, 2008.

    Google Scholar
28. 28.↵
    Fisher BioServices. Cold Chain Qualification: 5 Questions You Must Ask When Shipping Biologics, e-book, August 14, 2013.

    Google Scholar
29. 29.
    1. Zuleger B.,
    2. Werner U.,
    3. Kort A.,
    4. Glowienka R.,
    5. Wehnes E.,
    6. Duncan D.

    Container/Closure Integrity Testing and the Identification of a Suitable Vial/Stopper Combination for Low-Temperature Storage at −80° C. PDA J. Pharm. Sci. Technol. 2012, 66 (5), 453–465.

    OpenUrlAbstract/FREE Full TextGoogle Scholar